Mereo BioPharma Group Statistics
Total Valuation
MREO has a market cap or net worth of $43.92 million. The enterprise value is $18.40 million.
Important Dates
The last earnings date was Monday, November 9, 2026, before market open.
| Earnings Date | Nov 9, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MREO has 159.70 million shares outstanding. The number of shares has increased by 1.49% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 159.70M |
| Shares Change (YoY) | +1.49% |
| Shares Change (QoQ) | +0.12% |
| Owned by Insiders (%) | 0.75% |
| Owned by Institutions (%) | 16.47% |
| Float | 122.51M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 57.26 |
| Forward PS | n/a |
| PB Ratio | 1.95 |
| P/TBV Ratio | 1.94 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 25.36 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.22, with a Debt / Equity ratio of 0.02.
| Current Ratio | 5.22 |
| Quick Ratio | 4.86 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -423.14 |
Financial Efficiency
Return on equity (ROE) is -76.63% and return on invested capital (ROIC) is -51.94%.
| Return on Equity (ROE) | -76.63% |
| Return on Assets (ROA) | -44.51% |
| Return on Invested Capital (ROIC) | -51.94% |
| Return on Capital Employed (ROCE) | -122.96% |
| Weighted Average Cost of Capital (WACC) | 5.41% |
| Revenue Per Employee | $20,513 |
| Profits Per Employee | -$690,718 |
| Employee Count | 39 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -84.89% in the last 52 weeks. The beta is 0.20, so MREO's price volatility has been lower than the market average.
| Beta (5Y) | 0.20 |
| 52-Week Price Change | -84.89% |
| 50-Day Moving Average | 0.31 |
| 200-Day Moving Average | 0.32 |
| Relative Strength Index (RSI) | 41.38 |
| Average Volume (20 Days) | 735,285 |
Short Selling Information
The latest short interest is 3.35 million, so 2.58% of the outstanding shares have been sold short.
| Short Interest | 3.35M |
| Short Previous Month | 3.23M |
| Short % of Shares Out | 2.58% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 3.48 |
Income Statement
In the last 12 months, MREO had revenue of $800,000 and -$26.94 million in losses. Loss per share was -$0.14.
| Revenue | 800,000 |
| Gross Profit | 800,000 |
| Operating Income | -29.62M |
| Pretax Income | -26.94M |
| Net Income | -26.94M |
| EBITDA | -28.67M |
| EBIT | -29.62M |
| Loss Per Share | -$0.14 |
Full Income Statement Balance Sheet
The company has $26.10 million in cash and $577,000 in debt, with a net cash position of $25.52 million or $0.16 per share.
| Cash & Cash Equivalents | 26.10M |
| Total Debt | 577,000 |
| Net Cash | 25.52M |
| Net Cash Per Share | $0.16 |
| Equity (Book Value) | 23.71M |
| Book Value Per Share | 0.15 |
| Working Capital | 23.18M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -22.09M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 955,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -22.09M |
| FCF Per Share | -$0.14 |
Full Cash Flow Statement Margins
| Gross Margin | 100.00% |
| Operating Margin | -3,702.50% |
| Pretax Margin | -3,367.25% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MREO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1.49% |
| Shareholder Yield | -1.49% |
| Earnings Yield | -52.00% |
| FCF Yield | -48.22% |
Analyst Forecast
The average price target for MREO is $1.95, which is 607.27% higher than the current price. The consensus rating is "Buy".
| Price Target | $1.95 |
| Price Target Difference | 607.27% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 163.97% |
| EPS Growth Forecast (3Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MREO has an Altman Z-Score of -14.9 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -14.9 |
| Piotroski F-Score | 3 |